As of this writing, the FDA has not yet published the formal updated list, so BPC-157 remains technically banned
A protective mechanism of probiotic Lactobacillus against hepatic steatosis via reducing host intestinal fatty acid absorption (in Eng)
Also, BPC 157 attenuated and improved the postponed deleterious outcome (lower brain edema, significantly lower number and size of haemorrhagic traumatic lacerations, significantly lower intensity of subarachnoidal bleeding, significantly less intraventricular haemorrhage shown microscopically, declined fatality) (19)
It simply provides support for what your body is already trying to accomplish
I'm going up there talking about puppies afterwards
Oral administration allows the peptide to interact directly with the gastrointestinal lining, targeting areas of injury and promoting mucosal repair, angiogenesis, and barrier strengthening